These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22317812)

  • 1. A mapping between interactions and interference: implications for vaccine trials.
    VanderWeele TJ; Vandenbroucke JP; Tchetgen EJ; Robins JM
    Epidemiology; 2012 Mar; 23(2):285-92. PubMed ID: 22317812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On causal inference in the presence of interference.
    Tchetgen Tchetgen EJ; VanderWeele TJ
    Stat Methods Med Res; 2012 Feb; 21(1):55-75. PubMed ID: 21068053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects.
    Vanderweele TJ; Tchetgen Tchetgen EJ; Halloran ME
    Epidemiology; 2012 Sep; 23(5):751-61. PubMed ID: 22828661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarks on antagonism.
    VanderWeele TJ; Knol MJ
    Am J Epidemiol; 2011 May; 173(10):1140-7. PubMed ID: 21490044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
    Zhou J; Chu H; Hudgens MG; Halloran ME
    Stat Med; 2016 Jan; 35(1):53-64. PubMed ID: 26194767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive cluster level surrogacy in the presence of interference.
    Gabriel EE; Follmann DA
    Biostatistics; 2020 Apr; 21(2):e33-e46. PubMed ID: 30247535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emulating Target Trials to Improve Causal Inference From Agent-Based Models.
    Murray EJ; Marshall BDL; Buchanan AL
    Am J Epidemiol; 2021 Aug; 190(8):1652-1658. PubMed ID: 33595053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation and spillover effects in group-randomized trials: a case study of the 4Rs educational intervention.
    Vanderweele TJ; Hong G; Jones SM; Brown JL
    J Am Stat Assoc; 2013 Jun; 108(502):469-482. PubMed ID: 23997375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to spillover effects in cluster randomized trials with noncompliance.
    Keele L; Kang H
    Clin Trials; 2022 Aug; 19(4):375-379. PubMed ID: 35510562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal interactions in the proportional hazards model.
    VanderWeele TJ
    Epidemiology; 2011 Sep; 22(5):713-7. PubMed ID: 21558856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine trial data systematically assembled, pooled and disseminated by the Cochrane Collaboration.
    Jefferson T
    Vaccine; 1998 Oct; 16(16):1487-95. PubMed ID: 9711794
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing effects of cholera vaccination in the presence of interference.
    Perez-Heydrich C; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2014 Sep; 70(3):731-44. PubMed ID: 24845800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal inference based on counterfactuals.
    Höfler M
    BMC Med Res Methodol; 2005 Sep; 5():28. PubMed ID: 16159397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on 'Evaluating a surrogate endpoint at three levels, with application to vaccine development' by Peter B. Gilbert, Li Qin and Steven G. Self, Statistics in Medicine, DOI: 10.1002/sim.3122.
    Dunning AJ
    Stat Med; 2008 Dec; 27(29):6268-70. PubMed ID: 18767203
    [No Abstract]   [Full Text] [Related]  

  • 15. Causal inference for vaccine effects on infectiousness.
    Halloran ME; Hudgens MG
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal inference concepts applied to three observational studies in the context of vaccine development: from theory to practice.
    Gvozdenović E; Malvisi L; Cinconze E; Vansteelandt S; Nakanwagi P; Aris E; Rosillon D
    BMC Med Res Methodol; 2021 Feb; 21(1):35. PubMed ID: 33588764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented designs to assess immune response in vaccine trials.
    Follmann D
    Biometrics; 2006 Dec; 62(4):1161-9. PubMed ID: 17156291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.
    Conlon A; Taylor J; Li Y; Diaz-Ordaz K; Elliott M
    Stat Med; 2017 Nov; 36(27):4243-4265. PubMed ID: 28786131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bounding the infectiousness effect in vaccine trials.
    VanderWeele TJ; Tchetgen Tchetgen EJ
    Epidemiology; 2011 Sep; 22(5):686-93. PubMed ID: 21753730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tutorial: A nontechnical explanation of the counterfactual definition of effect modification and interaction.
    Bours MJL
    J Clin Epidemiol; 2021 Jun; 134():113-124. PubMed ID: 33548464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.